ENDRA Life Sciences Inc. (NDRA) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ENDRA Life Sciences Inc. (NDRA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

5.92

0.19 (3.32%)

At close: Jan 14, 2025, 12:28 PM

5.92

0.00%

After-hours Jan 14, 2025, 12:28 PM EST

undefined% (undefined)

Bid	5.89
Market Cap	3.18M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-105.78
PE Ratio (ttm)	-0.06
Forward PE	n/a
Analyst	Buy

Ask	7.15
Volume	4,569
Avg. Volume (20D)	276,623
Open	5.74
Previous Close	5.73
Day's Range	5.72 - 5.95
52-Week Range	4.01 - 2397.50
Beta	undefined

About NDRA

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagno...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Jun 30, 2017

Employees 21

Stock Exchange NASDAQ

Ticker Symbol NDRA

Website https://www.endrainc.com

Analyst Forecast

According to 1 analyst ratings, the average rating for NDRA stock is "Buy." The 12-month stock price forecast is $14000, which is an increase of 236386.49% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

2 months ago · Source

-14.18%

ENDRA Life Sciences shares are trading lower. The ... Unlock content with Pro Subscription

2 months ago · Source

+89.02%

ENDRA Life Sciences shares are trading higher after the company announced the activation of a post market clinical study of the TAEUS liver system.

News

1 month ago · businesswire.com

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it has regained compliance with the minim...

2 months ago · businesswire.com

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months en...

2 months ago · businesswire.com

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office has issued to ENDRA a n...